Saudi Arabia’s medical device market poised to grow at 5.4% CAGR until 2028 | Healthcare Asia Magazine
, Middle East
Photo from Pavel Danilyuk on Pexels

Saudi Arabia’s medical device market poised to grow at 5.4% CAGR until 2028

The expansion is driven by the Kingdom’s Vision 2030 health objectives.

Saudi Arabia’s medical devices market is expected to rise steadily at a compound annual growth rate (CAGR) of 5.4% until 2028 in line with the Kingdom’s Vision 2030 health objectives, according to BMI.

The report revealed that an acceleration in economic growth in the near term, supported by a stabilisation in the oil economy will boost investments in strategic healthcare objectives.

“This will include progress towards expanding healthcare coverage, healthcare system enhancements and improving medical outcomes, which are key aims of the government’s Vision 2030 healthcare objectives,” BMI said.

In line with this, Saudi Arabia’s efforts to develop its healthcare system contribute to the demand for digitally enabled and artificial intelligence (AI) driven medical devices for improved efficiency and quality of healthcare procedures.

Moreover, the demand for advanced medical devices is expected to present opportunities for multinational medical device companies to market their products in the kingdom, further supporting the sector’s growth.

However, Saudi Arabia’s domestic medical device industry remains limited to the production of low-margin products such as syringes, masks, and surgical gloves.

According to the report, the value of medical device imports at $1.8b dwarfed the country’s exports at $27.8m in 2022.

“Due to the minimal domestic base, we expect the market will remain heavily reliant on imported medical devices over the near to medium term, particularly for advanced imaging and digitally enabled products,” BMI added.

 

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.